TWEAK/Fn14 Signaling in Muscle Aging
Current understanding
TWEAK (TNFSF12) signaling through its receptor Fn14 is emerging as an inflammatory cytokine axis proposed to drive age-related skeletal muscle wasting by suppressing mitochondrial biogenesis and amplifying p38 MAPK-linked catabolic signaling. Preclinical C2C12 and aged-mouse AAV-knockdown work indicates TWEAK suppression enhances mitochondrial biogenesis via AMPK activation and attenuates age-related muscle mass loss, though a functional grip-strength benefit was not shown, keeping this at target-validation stage [animal-model]. No human translation exists; the mechanistic case is preclinical only and the standing area caveat about model-to-human translation applies.
Evidence log
- 2026-08-14 — Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss.: cross-connection with myokines-muscle-aging: TWEAK/Fn14 sits alongside canonical myokine signaling as a muscle-active cytokine axis whose suppression enhances mitochondrial biogenesis in aged muscle, extending the inflammatory-cytokine side of muscle-aging beyond myokine loss. (novelty: 3)